IL17A and asthma: From these, the autoantibody of IL-17A induced by recombinant Mycobacterium smegmatis effectively inhibited the expression levels of IL-17A and IL-6, it not only could suppress the eosinophilic inflammation through regulating the Th1/Th2 balance, but also attenuate the neutrophilic airway inflammation in asthma.